Veru Inc. (NASDAQ: VERU), a late clinical stage biopharmaceutical company focused on developing innovative medicines for preserving muscle for high quality weight loss, oncology, and viral induced ...
Novo Nordisk's CagriSema trial raised concerns as patients reported weight loss but significant side effects. Investors ...
What is Mounjaro and how does the weight-loss jab work? Pharmacies to face stricter checks for popular drug - Pharmacists who ...
Novo Nordisk NVO is scheduled to report fourth-quarter 2024 results on Feb. 5, 2025, before the opening bell. The Zacks ...
In fact, Novo Nordisk recently reported positive results for one of its anti-obesity candidates that puts its current ...
More and more people are taking weight loss injectables like Wegovy — but not everyone prescribed these drugs should have ...
The AP-NORC survey shows about half of U.S. adults believe it is a good thing for adults to use Ozempic, Wegovy and similar ...
From Aug. 1 to the end of the year, Medicaid beneficiaries received 33,035 claims for GLP-1 drugs for weight loss, a number ...
While GLP-1 therapies like Ozempic gain traction, personalized peptide therapies are supporting long-term health goals ...
These compounds take a different approach to weight loss than existing medications, which can cause nausea, vomiting and ...
Americans are split on using weight loss drugs such as Ozempic and Wegovy to treat obesity or weight-related conditions, according to a new survey that was published on Friday. The new ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback